Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Brunori

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal De La Societe De Biologie|September 17, 2004
[The opposite roles of telomerase during initiation and progression of cancers]Michele Brunori, Eric Gilson
Medecine Sciences : M/S|January 11, 2005
[Telomere and cancer: what's more at the end?]Michele Brunori, Eric Gilson
Journal of Molecular Medicine (Berlin, Germany)|January 5, 2005
The telomerase cycle: normal and pathological aspectsMichele Brunori, Pierre Luciano, Eric Gilson, et al.
Brain Research. Developmental Brain Research|April 6, 2004
Change in nuclear-cytoplasmic localization of a double-bromodomain protein during proliferation and differentiation of mouse spinal cord and dorsal root gangliaThomasE Crowley, Michele Brunori, Kunsoo Rhee, et al.
Current Biology : CB|May 30, 2006
The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repairChristelle Lenain, Serge Bauwens, Simon Amiard, et al.
Arthritis Research & Therapy|April 22, 2026
Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA<sup>®</sup> in the United Kingdom using data from a national registerArgentina E Servin, Mark Lillie, Ran Jin, et al.
Molecular and Cellular Biology|April 25, 2002
Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2Katia Ancelin, Michele Brunori, Serge Bauwens, et al.
Rheumatology and Therapy|September 18, 2021
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled TrialsPhilip J Mease, Dafna D Gladman, Arthur Kavanaugh, et al.
EMBO Reports|October 24, 2002
Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrityCatherine Elaine Koering, Alessandra Pollice, Maria Pia Zibella, et al.
Arthritis Care & Research|January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease ManifestationsPhilip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal De La Societe De Biologie|September 17, 2004
[The opposite roles of telomerase during initiation and progression of cancers]Michele Brunori, Eric Gilson
Medecine Sciences : M/S|January 11, 2005
[Telomere and cancer: what's more at the end?]Michele Brunori, Eric Gilson
Journal of Molecular Medicine (Berlin, Germany)|January 5, 2005
The telomerase cycle: normal and pathological aspectsMichele Brunori, Pierre Luciano, Eric Gilson, et al.
Brain Research. Developmental Brain Research|April 6, 2004
Change in nuclear-cytoplasmic localization of a double-bromodomain protein during proliferation and differentiation of mouse spinal cord and dorsal root gangliaThomasE Crowley, Michele Brunori, Kunsoo Rhee, et al.
Current Biology : CB|May 30, 2006
The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repairChristelle Lenain, Serge Bauwens, Simon Amiard, et al.
Arthritis Research & Therapy|April 22, 2026
Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA<sup>®</sup> in the United Kingdom using data from a national registerArgentina E Servin, Mark Lillie, Ran Jin, et al.
Molecular and Cellular Biology|April 25, 2002
Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2Katia Ancelin, Michele Brunori, Serge Bauwens, et al.
Rheumatology and Therapy|September 18, 2021
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled TrialsPhilip J Mease, Dafna D Gladman, Arthur Kavanaugh, et al.
EMBO Reports|October 24, 2002
Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrityCatherine Elaine Koering, Alessandra Pollice, Maria Pia Zibella, et al.
Arthritis Care & Research|January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease ManifestationsPhilip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Pageof 2